Approval · Notice of Compliance 28135 · 2022
TEPADINA: Notice of Compliance 28135
Issued May 11, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28135
- Date
- May 11, 2022
- Company
- Adienne SaLugano, Tessin, Switzerland
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in drug product manufacturing process. Change in the controls applied during the manufacturing process.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEPADINA | Not yet assigned | — |
Medicinal ingredients
- THIOTEPA 100 MG per VIAL